Sunwin ( SUWN ) explodiert !
Seite 2 von 102 Neuester Beitrag: 25.04.21 03:17 | ||||
Eröffnet am: | 24.01.06 12:38 | von: gameznman | Anzahl Beiträge: | 3.526 |
Neuester Beitrag: | 25.04.21 03:17 | von: Brigitteojnfa | Leser gesamt: | 532.702 |
Forum: | Hot-Stocks | Leser heute: | 8 | |
Bewertet mit: | ||||
Seite: < 1 | | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... 102 > |
WKN: A0D9SL ISIN: US8678771028
Geld: 0,47 Vol.: 7000
Brief: 0,49 Vol.: 8000
Zeit: 14:58:06 Datum: 25.01.2006
Sunwin International Neutraceuticals to Host a Series of Investor Presentations
NEW YORK, NY and QUFU, CHINA -- (MARKET WIRE) -- 01/25/06 -- Sunwin International Neutraceuticals, Inc. (OTC BB: SUWN), a leader in the production and distribution of Chinese herbs, veterinary medicines and low calorie natural sweetener (Stevia) in China, announced it will host a series of investor conferences to communicate the Company's business strategy, acquisition developments, and growth potential to the investment community. The conferences are part of a campaign launched by the Company in the fourth quarter of 2005. Please visit investor sector at http://www.sunwin.biz for a full itinerary.
Sunwin Investor Conference Itinerary
-- The World Money Show, February 1-4, 2006, in Orlando, Florida. SUWN
will host a series of one-on-one meetings, luncheons, and dinner events
during the week.
-- Investor luncheon - Boca Raton, FL, February 9, 2006, 12pm - 2pm
(EST), Maggiano's Restaurant, 21090 St. Andrews Blvd, Boca Raton, Florida.
-- Investor luncheon - February 20, 2006 12:30pm - 3:00 pm (PST) at
Chanticlair Restaurant, 18912 MacArthur Blvd, Newport Beach, California.
-- Roth Capital Micro-Cap Conference, February 20-22, 2006. SUWN will
host a series of one-on-one meetings at the St. Regis Monarch Beach Resort
& Spa, 33000 Niguel Road, Dana Point, CA.
-- Investor luncheon - February 22, 2006, 1pm - 3pm (PST), Mr. Chow's
Restaurant, 344 N Camden Drive, Beverly Hills, California.
All shareholders and prospective investors are welcome. Please RSVP at info@sunwin.biz.
Mr. Alan Stone, Managing Director of ASC, stated, "We have arranged a comprehensive program for SUWN representatives to meet with a wide range of market professionals. Our goal is to present the Company's exciting accomplishments and growth opportunities to the broader investment community. Demand for Chinese related securities remains strong; we believe that the planned events and activities will improve the Company's visibility on Wall Street, broaden its shareholder base, increase the stock's trading liquidity and enhance long-run shareholder value."
About Sunwin International Neutraceuticals, Inc.
Sunwin International Neutraceuticals, Inc. (OTC BB: SUWN) is engaged in the areas of essential traditional Chinese medicine, 100% organic herbal medicine, neutraceutical products, natural sweetener (Stevia), and veterinary medicines and feeds prepared from 100% organic herbal ingredients. As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. The Sunwin family works closely with consumers to provide a quality and a hybrid mix of agricultural products and services that meet growing demand. In 2002, Sunwin was recognized as one of the first 2,000 state-level companies that China authorized as the most important innovative high-tech pioneer businesses by the Chinese central government. In 2002, Sunwin was awarded as one of 2002 state-level biological product manufacturers in China. In 2003, Sunwin ranked as one of the top 50 companies of China Animal Related Health Care Product Pharmaceutical Industry. In 2003, Sunwin received the award of Shandong Top-Ten Innovative, High-Tech Businesses by the Province Government of Shandong. For more info about Sunwin, please visit http://www.sunwin.biz/
Safe Harbor Statement
Certain of the statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted, and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.
Contact:
John S. Keffalas
Senior Associate
Alan Stone & Company, LLC
Phone: 949-233-2972
E-mail: johnskeffalas@hotmail.com
Alan Stone
Managing Director
Alan Stone & Company, LLC
Phone: 212-521-4102
E-mail: astone@alanstone.com
mfg
S.H.
Sunwin International Neutraceuticals Retains Alan Stone & Company, LLC to Spearhead Investor Awareness Campaign
NEW YORK, NY and QUFU, CHINA -- (MARKET WIRE) -- 01/24/06 -- Sunwin International Neutraceuticals, Inc. (OTC BB: SUWN), a leader in the production and distribution of Chinese herbs, veterinary medicines and low calorie natural sweetener (Stevia) in China, has retained Alan Stone & Company, LLC ("ASC") to provide a full range of investor relations, road show, and media services. ASC will commence and maintain an investor relations and road show campaign aimed at enhancing visibility of SUWN, and enhancing shareholder value. ASC will communicate SUWN's business strategy, acquisition developments, financing plans and growth potential to investors.
As part of its effort, ASC will be arranging a series of meetings over the next several months in New York City, California, and Florida. Through its affiliate WallStreet Research (WSR, www.WallStreetResearch.org), WSR has recently been providing independent research coverage on SWUN, with its most current update report completed on January 4th, which can be viewed at www.WallStreetResearch.org.
Mr. Laiwang Zhang, Chairman & President of SUWN, commented, "We are very excited about working with Alan Stone & Company, LLC (www.AlanStone.com), as we are determined to increasing value for our shareholders. One of two important initiatives in 2006 for us is to have better communication with the investment community. ASC with offices in New York City, Los Angeles, and Palm Beach, FL is well positioned to assist us in communicating our story to the investment community. ASC has an impressive track record of enhancing shareholder value and attracting investment capital for its publicly traded small-cap clients and is well respected on Wall Street. It also has valuable experience in working with several successful, rapidly growing Chinese clients listed on U.S. Capital Markets. ASC has very senior level associates who understand our business plans very well and have solid long-term relationships on Wall Street."
Mr. Alan Stone, founder and Managing Director of ASC, stated, "We are delighted to expand our overall relationship with Sunwin International Neutraceuticals, Inc. We have found SUWN to be consistent in meeting its financial expectations and milestones, and our expanded involvement is an indication of management's desire to communicate their tremendous growth plans during 2006 and beyond. We believe this positions them well for enhanced shareholder values."
Mr. Stone concluded, "China's economy continues to grow quite rapidly, aided by significant population growth, increasing income levels and global exports. The listing of successful rapidly growing China based companies in the U.S. Capital Markets is an increasingly popular trend, affording access to significant capital market opportunities, enhanced shareholder values and liquidity. We believe that our program will assist the Company in obtaining greater liquidity on the market, broadening its shareholder base, realizing greater visibility among investors of emerging growth companies and enhancing shareholder value. We look forward to beginning this campaign with the SUWN management team."
About Sunwin International Neutraceuticals, Inc.
Sunwin International Neutraceuticals, Inc. (OTC BB: SUWN) is engaged in the areas of essential traditional Chinese medicine, 100% organic herbal medicine, neutraceutical products, natural sweetener (Stevia), and veterinary medicines and feeds prepared from 100% organic herbal ingredients. As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. The Sunwin family works closely with consumer to provide a quality and a hybrid mix of agricultural products and services that meet growing demand. In 2002, Sunwin was recognized as one of the first 2,000 state-level companies that China authorized as the most important innovative high-tech pioneer businesses by the Chinese central government. In 2002, Sunwin was awarded as one of 2002 state-level biological product manufacturers in China. In 2003, Sunwin ranked as one of the top 50 companies of China Animal Related Health Care Product Pharmaceutical Industry. In 2003, Sunwin received award of Shandong Top-Ten Innovative, High-Tech Businesses by the Province Government of Shandong. For more info about Sunwin, please visit http://www.sunwin.biz
Safe Harbor Statement
Certain of the statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.
Contact:
Market Solutions, LLC
Tel: 561-487-3674
Fax: 561-237-2925
Email: info@sunwin.biz
Alan Stone & Company, LLC
Alan Stone
Managing Director
Tel: 212-521-4102
Email: astone@alanstone.com
mfg
S.H.
mfg
S.H.
Ansicht: Jährliche Daten | Vierteljährliche Daten Alle Zahlen in den Tausenden
PERIODENCEnde 30-Apr-05 30-Apr-04 30-Apr-03
GesamtcEinkommen 12,114 10,888 -
Absatzkosten 8,379 7,750 -
Bruttogewinn 3,735 3,138 -
Betriebskosten
ForschungEntwicklung - - -
Verkaufen allgemein
administrativ 2,110 2,164 29
GesamtcBetriebskosten
Gewinn / Verlust 1,625 974 (29)
Einkommen von fortfahrenden Betrieben
Zählen Sie Anderes Income-/ExpensescNetz 59 48 20
Einkommen Vor Interesse u Steuern 1,684 1,022 (9)
InteressencUnkosten 62 59 -
Einkommen Vor Steuer 1,622 963 (9)
EinkommenssteuercUnkosten 513 353 -
Minderheitsbeteiligung (279) (145) -
Reineinkommen Vom Fortsetzen Von Ops 829 465 (9)
Nicht wiederkehrende Fälle
Eingestellte Betriebe - - -
Außerordentliche Einzelteile - - -
Effekt Der Rechnungsänderungen - - -
Andere Einzelteile - - -
Reineinkommen 829 465 (9)
Vorzugsaktie Und Andere Justagen - - -
Reineinkommen Auf Allgemeine Anteile $829 $465 ($9
Durch automatische übersetzung etwas holbrig aber doch aussagekräftig.
gruß Lavati
Ich denke das es noch einige wochen die 0,50-0,80 cent sein werden aber dann den euro überrennen.
Hier seckt Potential auch weil die Sunwin gerade einer der Pioniere in ihrem eigenen Land sind.
Die schreiben (Mr. Laiwang Zhang, Chairman & President of SUWN ) ja selber das Sunwin nicht lange im Pennystock herumkrazeln will.
Hier können einige nochmal nachlesen http://www.sunwin.biz
WKN: A0D9SL ISIN: US8678771028
Geld: 0,39 Vol.: 10000
Brief: 0,41 Vol.: 30000
Zeit: 09:00:16 Datum: 25.01.2006
Geld: 0,40 Vol.: 20000
Brief: 0,41 Vol.: 25000
Zeit: 09:04:55 Datum: 25.01.2006
Ich glaub ich werd gleich mal 30 Stück davon verkaufen und mir vom Erlös einen guten Beruhigungstee aus der Apotheke holen ;-)
Bin mit 0,46 und 0,37 reingegangen....
Bis 1 oder 1,50€ wird da locker noch Luft sein bis August, September.
mfg
S.H.
webzen und sunwin - die kriegen vorläufig meine kohle......bis seite 28 bin ich gekommen und hab auch nicht mehr flüssiges;)
WKN: A0D9SL ISIN: US8678771028
Geld: 0,50 Vol.: 2500
Brief: 0,52 Vol.: 2500
Zeit: 08:28:38 Datum: 26.01.2006
Geld: 0,51 Vol.: 5500
Brief: 0,54 Vol.: 2500
Zeit: 08:34:01 Datum: 26.01.2006